As shown in Figures 4F–I, silencing HDAC11 suppressed HCC cell proliferation and rendered SMMC7721 and SMMC7721/SR cells more sensitive to sorafenib. The gene discussed is HDAC11; the disease is hepatocellular carcinoma.